← Pharmaceutical Executive6 days ago · 3 min

Pharmaceutical Executive Daily: FDA Approves Tecentriq

Pharmaceutical Executive Daily: FDA Approves Tecentriq6 days ago3 min

Listen on SpotifyAlso works in your browser

Apple PodcastsOpen
Pocket Castsopens the podcast
Amazon Musicopens the podcast
Deezeropens the podcast
Overcastopens the podcast

11 more apps

Player FMopens the podcast
Castroopens the podcast
Podcast Addictopens the podcast
YouTubeOpen
Castboxopens the podcast
Podcast Republicopens the podcast
AntennaPodopens the podcast
iHeartRadioopens the podcast
TuneInopens the podcast
Fountainopens the podcast

The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.